Joanna Krezel-Niesiobedzka
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.
Journal: Journal of cancer research and clinical oncology
Published: December 03, 2022
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 06, 2022
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 06, 2021
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 30, 2018
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry.
Journal: American journal of hematology
Published: March 09, 2017
Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib.
Journal: Experimental hematology
Published: January 17, 2014
Differential expression of BIRC family genes in chronic myeloid leukaemia--BIRC3 and BIRC8 as potential new candidates to identify disease progression.
Journal: British journal of haematology
Published: November 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026